Aeglea raises $50M in IPO after slashing share price

John Carroll Austin, TC-based Aeglea BioTherapeutics raised $ 50 million in its IPO after pricing 5 million shares at $ 10 each, far below the range that it had set out for itself. FierceBiotech ...

Struggling Teva slashing R&D, chops 14 programs as it retreats on two fronts

John Carroll FierceBiotech News

Novartis slashing thousands more jobs in global reorganization, shifting many to India

Tracy Staton Novartis' 500 Swiss job cuts announced earlier this month are just the tip of a global iceberg. The company plans to cut or shuffle up to 4,000 jobs in its pharma business, ...

Isis steals diabetes drug spotlight with new approach to slashing blood fat

John Carroll In an R&D field typically characterized by slow progress and incremental gains, Isis Pharmaceuticals jumped out of the ADA pack in Chicago with some stellar mid-stage ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS